<DOC>
	<DOCNO>NCT02155608</DOCNO>
	<brief_summary>The purpose study develop external Trigeminal Nerve Stimulation ( eTNS ) potential nonmedication treatment attention-deficit/hyperactivity disorder ( ADHD ) . Study hypothesis address potential difference 4 week active vs. sham eTNS treatment ADHD symptom , measure executive function , electroencephalography ( EEG ) profile , dimensional measure height , weight , mood , anxiety , sleep , side effect profile .</brief_summary>
	<brief_title>Trigeminal Nerve Stimulation ADHD</brief_title>
	<detailed_description>This three-year developmental study double-blind randomized trial active vs. inactive sham eTNS ADHD , four week acute treatment follow additional four week clinical observation test treatment cessation . The study enroll 85-90 participant age 8-12 year achieve completion target N=36 study condition ( total final N = 72 ) . Participants meet Diagnostic Statistical Manual-5 ( DSM-5 ) criterion ADHD , current presentation , establish Behavior Disorders Module Kiddie Schedule Affective Disorders Schizophrenia ( KSADS-PL ) clinical interview . Other screen procedure include measure ADHD symptom severity , behavioral rating , cognitive assessment . Once inclusion/exclusion criterion review verify , participant pre-treatment visit establish behavioral cognitive baseline rating obtain EEG . Participants parent instruct use eTNS , participant begin use eTNS direct sleep night . Participants randomize 1:1 active inactive sham eTNS . Participants , family , study team remain blind treatment assignment . Participants weekly assessment eight week study assess behavioral , cognitive , brain activation change monitor safety , tolerability , compliance . Weekly rating obtain parent , teacher , clinician investigator . EEG occur baseline , end treatment ( week 4 ) .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<criteria>male female child age 8 12 year DSM5 ADHD , current presentation , determine KSADS clinical interview minimum score 12 inattentive hyperactive/impulsive subscales baseline ADHDRS CGIS score baseline ≥ 4 current medication CNS effect parent able willing monitor proper use stimulation device complete require rating scale estimate Full Scale IQ ≥ 80 base WASI subtests parent participant able complete rating scale measure English able cooperate EEG impair function degree require immediate initiation ADHD medication opinion parent and/or investigator current diagnosis autism spectrum disorder major depression history lifetime psychosis , mania , seizure disorder head injury loss consciousness baseline suicidality</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>ADHD</keyword>
	<keyword>neuromodulation</keyword>
	<keyword>trigeminal nerve stimulation</keyword>
	<keyword>cognition</keyword>
</DOC>